Fig. 1From: Treat-and-extend therapy using intravitreal aflibercept for neovascular age-related macular degeneration: 2-year real-world practice data from SloveniaMean VA ± SD from baseline to 24 months in eyes receiving treat-and-extend aflibercept for 2 years (n = 115) *p < 0.05. VA values refer to least-squares means. ETDRS: Early Treatment Diabetic Retinopathy Study; SD: standard deviation; VA: visual acuityBack to article page